Chargement de la fiche…
Chargement de la fiche…
MonRhumato.fr utilise des cookies pour mesurer l'audience (statistiques) et améliorer le site. Aucune donnée de santé identifiable n'est jamais collectée. Politique de confidentialité.
Votre choix est conservé 13 mois (durée max CNIL). Vous pouvez le modifier à tout moment via Préférences cookies.
6 raisons identifiées
Auteur de référence en rhumatologie
50 articles scientifiques publiés — un praticien à la pointe de la recherche
Encadrant universitaire
Forme la prochaine génération de rhumatologues (1 thèse dirigée)
En plein centre-ville
PARIS (75007) — accessible depuis tout le bassin urbain
Référence presse grand public
Cité 2 fois dans les médias — pédagogie reconnue
Disponibilité géographique
4 lieux d'exercice — choisissez celui qui vous arrange
Délais de RDV courts dans la région
336.2 rhumatos / 100 000 hab. — département bien doté
✨ Génération du profil synthétique IA en cours…
Données ANS publiques (Licence Ouverte 2.0) · Enrichissements MonRhumato 100 % opt-in · Toute personne référencée peut demander la suppression ou la rectification.
Source theses.fr — signal de direction d'équipe / statut PU-PH (à confirmer via le site universitaire).
Indicateurs publics agrégés sur 250 M+ d'œuvres scientifiques (OpenAlex, PubMed). Traduits ici en langage patient.
Influence scientifique
2
2 articles ont été cités au moins 2fois par d'autres chercheurs — preuve que ses travaux sont repris par la communauté médicale.
h-index
Total citations reçues
94
Nombre de fois où d'autres équipes ont mentionné ses publications dans leurs propres travaux.
Publications totales
3
Articles, revues et chapitres référencés dans les bases académiques internationales.
Articles influents
2
Publications ayant marqué leur domaine — chacune citée au moins 10 fois par d'autres chercheurs.
i10-index
Thématiques principales
Source : OpenAlex (CC0, OurResearch). Indicateurs académiques agrégés sur 250 M+ d'œuvres.
Articles déposés en accès libre sur l'archive ouverte des universités françaises (HAL) — gage d'activité de recherche en France.
Combined Oral Ivermectin and 5% Permethrin Cream to Treat Severe Scabies.
2026ArticleNew England Journal of Medicine
Combined methotrexate and short-term superpotent topical corticosteroids compared with prolonged superpotent topical corticosteroids alone in bullous pemphigoid: a multicentre, noninferiority randomised clinical trial
2026ArticleBritish Journal of Dermatology
Oral ivermectin versus 5% permethrin cream to treat children and adults with classic scabies: multicentre, assessor blinded, cluster randomised clinical trial
2026ArticleBMJ - British Medical Journal
Balanoposthitis due to Klebsiella aerogenes in men who have sex with men
2026ArticleJournal of the European Academy of Dermatology and Venereology
Antibiotic therapy in necrotizing soft tissue infections: a narrative review of the greater Paris SURFAST consortium
2025ArticleCritical Care
Mortality, functional outcome and health-related quality of life in patients with necrotizing skin- and soft tissue infections in the ICU: Protocol of a multinational prospective cohort study (SKIN-ICU)
2025ArticleInfectious Diseases Now
Efficacy and tolerance of dupilumab in patients with moderate‐to‐severe atopic dermatitis and obesity
2025ArticleJournal of the European Academy of Dermatology and Venereology
List of critical drugs in dermatology: results of a Delphi consensus in France
2025ArticleBritish Journal of Dermatology
Source : HAL — archive ouverte CCSD/CNRS (couvre articles, chapitres EMC, communications congrès, thèses).
CABINET DU DR Olivier CHOSIDOW
157 RUE DE L UNIVERSITE, 75007 PARIS
CABINET DU DR Olivier CHOSIDOW
POLE DE SANTE BERGERE 7 RUE BERGERE, 75009 PARIS
SERVICE DE SOINS PARIS GARE DE LYON
41 R DU CHAROLAIS, 75012 PARIS
CABINET DU DR Olivier CHOSIDOW
SISA MSP SAINT-TROPEZ 1 AVENUE DU GENERAL DE GAULLE, 83990 ST TROPEZ
Secteur de conventionnement non disponible (médecin hospitalier ou non présent dans l'Annuaire santé CNAM des libéraux conventionnés).
Lien Doctolib = recherche Google site:doctolib.fr (le 1er résultat est presque toujours le profil correct s'il existe).
Source : Google News (recherche par nom complet — homonymes possibles, vérifier le contenu).
📰 Doctissimo · 15/11/2022
<a href="https://news.google.com/rss/articles/CBMilgFBVV95cUxOSzg3VEZBcENzMDZjczZxUmtGRGQ5Y20yTTZHaWp5UkJEV1BkVVp0bGs2eWJnSlplTlRObGM0LVJLRzVTaFdBbkczTTBKZ09uUHh4UVFERGxpX0laRnZmcWFQNnc0Ukotb2d3aVJJY2FUVzkwUE5vY0N3cVp6MG43NTZsSFUxYWNUX2V0MGdrMXRTaGtrclE?oc=5" target="_blank">Verrues : quels traiteme
📰 Medscape · 17/02/2015
<a href="https://news.google.com/rss/articles/CBMiXkFVX3lxTE9BS1pqeEp3VDdvVlJxaWpEVDBhdExvVFBudDBCMXJBNGt1ZkF3S3hyQ1dnTWxkRlhJSGl4LUxTU0JPZzdHSnY3eTlGeFo1aU1EQmxlYUNQZnZPYkFxNmc?oc=5" target="_blank">Traiter la gale sans Ascabiol : un casse-tête</a> <font color="#6f6f6f">Medscape</font>
The Lancet. Infectious diseases · 2023
Journal of clinical medicine · 2022
Aseptic abscess (AA) syndrome is a rare type of inflammatory disorder involving polymorphonuclear neutrophils (PMNs), often associated with inflammatory bowel disease (IBD). This study sought to describe the clinical characteristics and evolution of this syndrome in a large cohort. We included all patients included in the French AA syndrome register from 1999 to 2020. All patients fulfilled the criteria outlined by André et al. in 2007. Seventy-one patients were included, 37 of which were men (52.1%), of a mean age of 34.5 ± 17 years. The abscesses were located in the spleen (71.8%), lymph nodes (50.7%), skin (29.5%), liver (28.1%), lung (22.5), and rarer locations (brain, genitals, kidneys, ENT, muscles, or breasts). Of all the patients, 59% presented with an associated disease, primarily IBD (42%). They were treated with colchicine (28.1%), corticosteroids (85.9%), immunosuppressants (61.9%), and biologics (32.3%). A relapse was observed in 62% of cases, mostly in the same organ. Upon multivariate analysis, factors associated with the risk of relapse were: prescription of colchicine (HR 0.52; 95% CI [0.28–0.97]; p = 0.042), associated IBD (HR 0.57; 95% CI [0.32–0.99]; p = 0.047), and hepatic or skin abscesses at diagnosis (HR 2.14; 95% CI [1.35–3.40]; p = 0.001 and HR 1.78; 95% CI [1.07–2.93]; p = 0.024, respectively). No deaths occurred related to this disease. This large retrospective cohort study with long follow up showed that AA syndrome is a relapsing systemic disease that can evolve on its own or be the precursor of an underlying disease, such as IBD. Of all the available treatments, colchicine appeared to be protective against relapse.
Source PubMed · Recherche par auteur (homonymes possibles, vérifier l'affiliation).
The New England journal of medicine · 2026 · Clinical Trial, Phase III
Bernigaud C, Do-Pham G, Guichard E, Beylot-Barry M, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV · 2026 · Letter
Maruani A, Barbarot S, Leducq S, Gangneux JP, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV · 2026 · Letter
Salle R, Monsel G, Fouéré S, Bouaziz JD, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV · 2026 · Letter
Cogrel O, Reybet-Degat P, Hotz C, Richard-Lallemand MA, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV · 2026 · Letter
Sigg N, Leducq S, Barbarot S, Sallé-Staumont D, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV · 2025 · Journal Article
Chosidow O, van Zuuren EJ
Journal of the European Academy of Dermatology and Venereology : JEADV · 2025 · Letter
Dupuis J, Tauber M, Mahe E, Jachiet M, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV · 2024 · Letter
Paucard L, Chosidow O, Bernigaud C, Walker SL, et al.
Journal of the American Academy of Dermatology · 2024 · Journal Article
Sagut P, Khamdan F, Al Awadhi A, Hua-Liang Lim J, et al.
EClinicalMedicine · 2024 · Journal Article
Kechichian E, Dupin N, Wetter DA, Ortonne N, et al.
Nature reviews. Disease primers · 2024 · Journal Article
Fernando DD, Mounsey KE, Bernigaud C, Surve N, et al.
American journal of clinical dermatology · 2024 · Journal Article
Salle R, Del Giudice P, Skayem C, Hua C, et al.
Clinical and experimental dermatology · 2023 · Journal Article
Salle R, Tubach F, Arlegui H, Curmin R, et al.
The British journal of dermatology · 2023 · Editorial
Chosidow O, Chang AY
Journal of the European Academy of Dermatology and Venereology : JEADV · 2023 · Letter
Mongereau M, Hua C, Urbina T, Woerther PL, et al.
The Lancet. Infectious diseases · 2023 · Journal Article
Hua C, Urbina T, Bosc R, Parks T, et al.
La Revue du praticien · 2023 · English Abstract
Hua C, Chosidow O
La Revue du praticien · 2023 · English Abstract
Hua C, Chosidow O
Journal of the European Academy of Dermatology and Venereology : JEADV · 2023 · Letter
Merio L, Chanal J, Jachiet M, Pourcher V, et al.
The Journal of allergy and clinical immunology · 2022 · Journal Article
Louvrier C, Awad F, Cosnes A, El Khouri E, et al.
The British journal of dermatology · 2022 · Letter
Chosidow O, Beylot-Barry M, Corgibet F, Jouan N, et al.
The British journal of dermatology · 2022 · Letter
Darrigade AS, Oulès B, Sohier P, Jullie ML, et al.
PLoS neglected tropical diseases · 2022 · Journal Article
Marks M, McVernon J, McCarthy JS, Enbiale W, et al.
Journal of clinical medicine · 2022 · Journal Article
Trefond L, Frances C, Costedoat-Chalumeau N, Piette JC, et al.
Acta dermato-venereologica · 2022 · Journal Article
Mahé E, Tubach F, Jullien D, Tran D, et al.
Therapie · 2022 · Case Reports
Braesch C, Weill A, Gaudin O, Lebrun-Vignes B, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV · 2026 · Letter
Guyomard V, Monsel G, Gavaud A, Faure K, et al.
Infectious diseases now · 2025 · Journal Article
Urbina T, Madsen MB, Hua C, Eckmann C, et al.
PLOS global public health · 2024 · Journal Article
Hansmann A, Wamba Lékémo G, Fomba C, Kaddoura J, et al.
The British journal of dermatology · 2026 · Journal Article
Dereure O, Bernard P, Chosidow O, Ingen-Housz-Oro S, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV · 2026 · Journal Article
Paris C, Curmin R, Gouillon L, Giboin C, et al.
JAMA dermatology · 2023 · Randomized Controlled Trial
Joly P, Lafon A, Houivet E, Donnadieu N, et al.
BMJ (Clinical research ed.) · 2026 · Journal Article
Boralevi F, Simon G, Bernigaud C, Brun J, et al.
PLOS global public health · 2024 · Journal Article
Hansmann A, Wamba Lékémo G, Fomba C, Kaddoura J, et al.
Journal of the American Academy of Dermatology · 2024 · Multicenter Study
Ingen-Housz-Oro S, Guichard E, Milpied B, Bensaid B, et al.
Critical care (London, England) · 2025 · Journal Article
Charlier C, Souhail B, Dauger S, Woerther PL, et al.
Rheumatology (Oxford, England) · 2023 · Review
Demortier J, Vautier M, Chosidow O, Gallay L, et al.
Acta dermato-venereologica · 2023 · Review
Skayem C, Askour M, Gary C, Hemery F, et al.
BMJ (Clinical research ed.) · 2026 · Journal Article
Boralevi F, Simon G, Bernigaud C, Brun J, et al.
The British journal of dermatology · 2024 · Journal Article
Morand A, Weill A, Miquel J, Chosidow O, et al.
Journal of the American Academy of Dermatology · 2023 · Letter
Salle R, Skayem C, Hua C, Chosidow O, et al.
Journal of the American Academy of Dermatology · 2023 · Journal Article
Salle R, Hua C, Mongereau M, Giraud-Kerleroux L, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV · 2025 · Letter
Leymarie A, Thibon P, Bernigaud C, Daurel C, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV · 2023 · Letter
Tian Y, Hirsch G, Skayem C, Thomas E, et al.
Infectious diseases now · 2025 · Journal Article
Urbina T, Madsen MB, Hua C, Eckmann C, et al.
The British journal of dermatology · 2025 · Journal Article
Chaby G, Barbarot S, Corgibet F, Dauendorffer JN, et al.
Additional file 2: Figure S2. of In vitro activity of ten essential oils against Sarcoptes scabiei
The mites in fumigation bioassay observed under a stereomicroscope. The mites stayed firmly attached to the bottom of the Petri dish which has been turned over. (JPG 400 kb)
Long-term quality of life in necrotizing soft-tissue infection survivors: a monocentric prospective cohort study
Abstract Background Compared to other life-threatening infection survivors, long-term health-related quality of life (QOL) of patients surviving necrotizing soft-tissue infections (NSTI) and its determinants are little k
Impact of a multidisciplinary care bundle for necrotizing skin and soft tissue infections: a retrospective cohort study
Abstract Background Necrotizing skin and soft tissue infections (NSTIs) require both prompt medical and surgical treatment. The coordination of multiple urgent interventions by care bundles has improved outcome in other
Flow chart of the DRESS CODE Study
The trial was stopped prematurely (31/12/2017) owing to poor recruitment. In the end, 52 patients underwent randomization, 26 in each treatment group
Healthcare trajectory of critically ill patients with necrotizing soft tissue infections: a multicenter retrospective cohort study using the clinical data warehouse of Greater Paris University Hospitals
Abstract Background Necrotizing skin and soft tissue infections (NSTIs) are rare but serious and rapidly progressive infections characterized by necrosis of subcutaneous tissue, fascia and even muscle. The care pathway o
Healthcare trajectory of critically ill patients with necrotizing soft tissue infections: a multicenter retrospective cohort study using the clinical data warehouse of Greater Paris University Hospitals
Abstract Background Necrotizing skin and soft tissue infections (NSTIs) are rare but serious and rapidly progressive infections characterized by necrosis of subcutaneous tissue, fascia and even muscle. The care pathway o
Source : DataCite — DOIs pour datasets, logiciels, protocoles, registres patient. Hors articles (déjà couverts).
Journal of the European Academy of Dermatology and Venereology : JEADV · 2023 · Letter
Salle R, Chosidow O, Fihman V, de Prost N, et al.
Journal of the American Academy of Dermatology · 2023 · Journal Article
Traineau H, Charpentier C, Lepeule R, Ingen-Housz-Oro S, et al.
Annals of intensive care · 2023 · Journal Article
Arrestier R, Chaba A, Mabrouki A, Saccheri C, et al.
The British journal of dermatology · 2023 · Journal Article
Aubert H, Arlegui H, De Rycke Y, Bachelez H, et al.
Annals of intensive care · 2022 · Journal Article
Windsor C, Hua C, De Roux Q, Harrois A, et al.
JAMA dermatology · 2022 · Journal Article
van Huizen AM, Menting SP, Gyulai R, Iversen L, et al.
Acta dermato-venereologica · 2023 · Journal Article
Do-Pham G, Maruani A, Leducq S, Giraudeau B, et al.